218 related articles for article (PubMed ID: 21739196)
1. MicroRNA signature analysis in colorectal cancer: identification of expression profiles in stage II tumors associated with aggressive disease.
Chang KH; Miller N; Kheirelseid EA; Lemetre C; Ball GR; Smith MJ; Regan M; McAnena OJ; Kerin MJ
Int J Colorectal Dis; 2011 Nov; 26(11):1415-22. PubMed ID: 21739196
[TBL] [Abstract][Full Text] [Related]
2. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
3. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
4. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
5. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
7. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality.
Slattery ML; Herrick JS; Mullany LE; Valeri N; Stevens J; Caan BJ; Samowitz W; Wolff RK
Int J Cancer; 2015 Jul; 137(2):428-38. PubMed ID: 25484364
[TBL] [Abstract][Full Text] [Related]
8. Mirna expression profiles identify drivers in colorectal and pancreatic cancers.
Piepoli A; Tavano F; Copetti M; Mazza T; Palumbo O; Panza A; di Mola FF; Pazienza V; Mazzoccoli G; Biscaglia G; Gentile A; Mastrodonato N; Carella M; Pellegrini F; di Sebastiano P; Andriulli A
PLoS One; 2012; 7(3):e33663. PubMed ID: 22479426
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.
Zhu Y; Peng Q; Lin Y; Zou L; Shen P; Chen F; Min M; Shen L; Chen J; Shen B
Oncotarget; 2017 Jan; 8(2):2233-2248. PubMed ID: 27903980
[TBL] [Abstract][Full Text] [Related]
10. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
12. Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.
Jung CK; Jung SH; Yim SH; Jung JH; Choi HJ; Kang WK; Park SW; Oh ST; Kim JG; Lee SH; Chung YJ
Oncotarget; 2016 May; 7(22):32902-15. PubMed ID: 27096956
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
[TBL] [Abstract][Full Text] [Related]
14. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.
Lee H; Park CS; Deftereos G; Morihara J; Stern JE; Hawes SE; Swisher E; Kiviat NB; Feng Q
World J Surg Oncol; 2012 Aug; 10():174. PubMed ID: 22925189
[TBL] [Abstract][Full Text] [Related]
17. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
[TBL] [Abstract][Full Text] [Related]
18. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
[TBL] [Abstract][Full Text] [Related]
19. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]